Adjuvant Treatment for Surgically-Treated Cervical Cancer Patients: A Comprehensive Review
This review emphasizes that achieving monotherapy remains pivotal to optimize outcomes and minimize overtreatment. Definitive adjuvant treatment is indicated for high-risk cases, and intermediate-risk patients may benefit from careful observation following adequate surgical intervention, pointing out the necessity of well-designed clinical trials.
Authors
- Alexandros Rodolakis (ORCID: https://orcid.org/0000-0001-9283-4480)
- Frédéric Guyon (ORCID: https://orcid.org/0000-0003-3740-1839)
- Chrysoula Margioula‐Siarkou (ORCID: https://orcid.org/0000-0002-2420-4003)
- Aristarchos Almperis (ORCID: https://orcid.org/0000-0002-2822-2452)
- Stamatios Petousis (ORCID: https://orcid.org/0000-0002-5564-0406)
- Konstantinos D. Dinas (ORCID: https://orcid.org/0000-0001-7144-2840)
- Vasilios Pergialiotis (ORCID: https://orcid.org/0000-0003-4510-1633)
- Nikolaos Thomakos
Institutions
- National and Kapodistrian University of Athens (GR)
- Aristotle University of Thessaloniki (GR)
- Institut Bergonié (FR)
Publication Details
- Journal
- Cancers
- Published
- 2025-11-20
- DOI
- https://doi.org/10.3390/cancers17223710
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00